Drug Profile
SRSS 025
Latest Information Update: 16 Apr 2004
Price :
$50
*
At a glance
- Originator Sirus
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS trauma
Most Recent Events
- 16 Mar 2004 Discontinued - Preclinical for CNS trauma in United Kingdom (unspecified route)
- 09 Jun 2003 Preclinical trials in CNS trauma in United Kingdom (unspecified route)